Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Moxifloxacin by Laboratorios Sophia for Bacterial Conjunctivitis: Likelihood of Approval
Moxifloxacin is under clinical development by Laboratorios Sophia and currently in Phase I for Bacterial Conjunctivitis. According to GlobalData, Phase...